Key Resources: Substance Abuse and Healthcare Costs

Citations from Key Results

Ahmed, A. T., Karter, A. J., & Liu, J. (2006). Alcohol consumption is inverstely assiciaed with adherence to diabetes self-care behaviours. Diabetic Medicine, 23(7), 795-802.

Amon, J. J., Garfein, R. S., Ahdieh-Grant, L., Armstrong, G. L., Ouellet, L. J., Latka, M. H., et al. (2008). Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clinical Infectious Diseases, 46(12), 1852-1858.

Bartels, S. J., Teague, G. B., Drake, R. E., Clark, R. E., Bush, P. W., & Noordsy, D. L. (1993). Substance abuse and schizophrenia: service utilization and costs. Journal of Nervous and Mental Disease 181(4), 227-232.

Baxter, J. D., Samnaliev, M., & Clark, R. E. (2008). Patterns of health care utilization for asthma treatment in adults with substance use disorders. Journal of Addiction Medicine, 2(2), 79-84.

Baxter, J. D., Samnaliev, M., & Clark, R. E. (2009). The quality of asthma care among adults with substance-related disorders and adults with mental illness. Psychiatric Services, 60(1), 43-49.

Brown, L. S., Kritz, S. A., Goldsmith, R. J., Bini, E. J., Rotrosen, J., Baker, S., et al. (2006). Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment, 30(4), 315-321.

Brown, L. S., Kritz, S., Goldsmith, R. J., Bini, E. J., Robinson, J., Alderson, D., et al. (2007). Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs. Public Health Reports, 122(4), 441-451.

Cavazos-Rehg, P. A., Spitznagel, E. L., Schootman, M., Strickland, J. R., Afful, S. E., Cottler, L. B., et al. (2009). Risky sexual behaviors and sexually transmitted diseases: a comparison study of cocaine-dependent individuals in treatment versus a community-matched sample. Aids Patient Care and Stds, 23(9), 727-734.

Centers for Disease Control. (2008). Smoking -Attributable Mortality, Years of Potential Life Lost, and Productivity Losses--United States, 2000-2004. Morbidity and Mortality Weekly Review, 57(45), 1226-1228.

Cisler, R., Holder, H. D., Longabaugh, R., Stout, R. L., & Zweben, A. (1998). Actual and estimated replication costs for alcohol treatment modalities: Case study from Project MATCH. Journal of Studies on Alcohol, 59(5).

Clark, R. E., Samnaliev, M., & McGovern, M. P. (2007). Treatment for co-occurring mental and substance use disorders in five state Medicaid programs. Psychiatr Serv, 58(7), 942-948.

Clark, R. E., Samnaliev, M., & McGovern, M. P. (2009). Impact of substance disorders on medical expenditures for Medicaid beneficiaries with behavioral health disorders. Psychiatric Services, 60(1), 35-42.

Clark, R. E., Weir, S., Ouellette, R. A., Zhang, J. Y., & Baxter, J. D. (2009). Beyond health plans behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries. Medical Care, 47(5), 545-552.

Cohen, J. T., Neumann, P. J., & Weinstein, M. C. (2008). Does preventive care save money? Health economics and the presidential candidates. The New England Journal of Medicine, 358(7), 661-663.

Dickey, B., & Azeni, H. (1996). Persons with dual diagnoses of substance abuse and major mental illness: Their excess costs of psychiatric care. American Journal of Public Health, 86(7), 973-977.

Dickey, B., Normand, S. L. T., Weiss, R. D., Drake, R. E., & Azeni, H. (2002). Medical morbidity, mental illness, and substance use disorders. Psychiatric Services, 53(7), 861-867.

Doran, C. M. (2008). Economic evaluation of interventions to treat opiate dependence - A review of the evidence. Pharmacoeconomics, 26(5), 371-393.

Edlin, B. R., & Carden, M. R. (2006). Injection drug users: The overlooked core of the hepatitis C epidemic. Clinical Infectious Diseases, 42(5), 673-676.

Ettner, S. L., Huang, D., Evans, E., Rose Ash, D., Hardy, M., Jourabchi, M., et al. (2006). Benefit-cost in the California Treatment Outcome Project: Does substance abuse treatment "Pay for Itself"? Health Services Research, 41(1), 192-213.

Finney, J. W., & Monahan, S. C. (1996). The cost-effectiveness of treatment for alcoholism: a second approximation. Journal of Studies on Alcohol, 57(3), 229-243.

Fox, K., Merrill, J. C., Chang, H. H., & Califano Jr, J. A. (1995). Estimating the costs of substance abuse to the Medicaid hospital care program. American Journal of Public Health, 85(1), 48.

Friedman, H., Pross, S., & Klein, T. W. (2006). Addictive drugs and their relationship with infectious diseases. FEMS Immunology and Medical Microbiology, 47(3), 330-342.

Garnick, D. W., Hendricks, A. M., Comstock, C., & Horgan, C. (1997). Do individuals with substance abuse diagnoses incur higher charges than individuals with other chronic conditions? Journal of Substance Abuse Treatment, 14(5), 457-465.

Goodman, A. C., Tilford, J. M., Hankin, J. R., Holder, H. D., & Nishiura, E. (2000). Alcoholism treatment offset effects: An insurance perspective. Medical Care Research and Review, 57(1), 51.

Harwood, H. (2000). Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data. Report prepared by The Lewin Group for the National Institute on Alcohol Abuse and Alcoholism. Rockville, MD: US Department of Health and Human Services.

Harwood, H. (2008). An Inventory of Cost Offset Studies for State Substance Abuse Agencies. Washington D.C.: National Association of State Alcohol/Drug Abuse Directors.

Holder, H. D. (1998). Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse. The Journal of Mental Health Policy and Economics, 1(1), 23-29.

Holder, H. D., & Blose, J. O. (1986). Alcoholism-treatment and total health-care utilization and costs - A 4 year longititudinal analysis of federal employees. [Article]. Journal of the American Medical Association, 256(11), 1456-1460.

Holloway, K. R., Bennett, T. H., & Farrington, D. P. (2006). The effectiveness of drug treatment programs in reducing criminal behavior: A meta-analysis. PSICOTHEMA-OVIEDO-, 18(3), 620.

Hser, Y. I., & Evans, E. (2008). Cross-system data linkage for treatment outcome evaluation: Lessons learned from the California Treatment Outcome Project. Evaluation and program planning, 31(2), 125-135.

Hubbard, R. L., Craddock, S. G., & Anderson, J. (2003). Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). Journal of Substance Abuse Treatment, 25(3), 125-134.

Jackson, J. L., & Kroenke, K. (2001). The effect of unmet expectations among adults presenting with physical symptoms. Annals of Internal Medicine, 134(9), 889.

Kang, S. Y., & Deren, S. (2009). Factors mediating and moderating the relationship between gender and utilization of health care among Puerto Rican drug users in New York. [Article]. Drug and Alcohol Dependence, 102(1-3), 138-143.

Kertesz, S. G., Pletcher, M. J., Safford, M., Halanych, J., Kirk, K., Schumacher, J., et al. (2007). Illicit drug use in young adults and subsequent decline in general health: The coronary artery risk development in young adults (CARDIA) study. Drug and Alcohol Dependence, 88(2-3), 224-233.

Kessler, R. C. (2004). The epidemiology of dual diagnosis. Biological Psychiatry, 56(10), 730-737.

Khalsa, J. H., Treisman, G., McCance-Katz, E., & Tedaldi, E. (2008). Medical Consequences of Drug Abuse and Co-occurring Infections: Research at the National Institute on Drug Abuse. Substance Abuse, 29(3), 5-16.

Kuehn, B. M. (2008). Integrated care needed for patients with HIV, drug abuse, and mental illness. Journal of the American Medical Association, 300(5), 494-495.

Mark, T. L., Levit, K. R., Vandivort-Warren, R., Coffey, R. M., Buck, J. A., & Team, S. S. E. (2007). Trends in spending for substance abuse treatment, 1986-2003. Health Affairs, 26(4), 1118-1128.

McCollister, K. E., & French, M. T. (2003). The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings. Addiction, 98(12), 1647-1659.

McCoy, C. B., Metsch, L. R., Chitwood, D. D., & Miles, C. (2001). Drug use and barriers to use of health care services. Substance Use & Misuse, 36(6-7), 789-806.

McGeary, K. A., & French, M. T. (2000). Illicit drug use and emergency room utilization. Health Services Research, 35(1 Part 1), 153.

Mehta, S. H., Thomas, D. L., Sulkowski, M. S., Safaein, M., Vlahov, D., & Strathdee, S. A. (2005). A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS, 19(Suppl. 3), S179-S189.

Mertens, J. R., Flisher, A. J., Fleming, M. F., & Weisner, C. M. (2007). Medical conditions of adolescents in alcohol and drug treatment: Comparison with matched controls. Journal of Adolescent Health, 40(2), 173-179.

Mertens, J. R., Lu, Y. W., Parthasarathy, S., Moore, C., & Weisner, C. M. (2003). Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO - Comparison with matched controls. Archives of Internal Medicine, 163(20), 2511-2517.

Metsch, L. R., Pereyra, M., Miles, C. C., & McCoy, C. B. (2003). Welfare and work outcomes after substance abuse treatment. Social Service Review, 77(2), 237-254.

Narevic, E., Garrity, T. F., Schoenberg, N. E., Hiller, M. L., Webster, J. M., Leukefeld, C. G., et al. (2006). Factors predicting unmet health services needs among incarcerated substance users. Substance Use & Misuse, 41(8), 1077-1094.

National Center on Addiction and Substance Abuse at Columbia University. (2009). Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Budgets. New York: The National Center on Addiction and Substance Abuse at Columbia University.

National Institute on Drug Abuse. (2008). NIDA InfoFacts: Drug Abuse and the link to HIV/AIDS and Other Infectious Diseases. Retrieved October 19, 2009, from http://www.nida.nih.gov/Infofacts/DrugAbuse.html

Oeltmann, J. E., Kammerer, J. S., Pevzner, E. S., & Moonan, P. K. (2009). Tuberculosis and substance abuse in the United States, 1997-2006. Archives of Internal Medicine, 169(2), 189-197.

Office of National Drug Control Policy. (2004). The Economic Costs of Drug Abuse in the United States, 1992-2002. Washington, DC: Executive Office of the President (Publication No. 207303).

Owens, P., Myers, M., Elixhauser, A., & Brach, C. (2007). Care of Adults With Mental Health and Substance Abuse Disorders in U.S. Community Hospitals, 2004. Agency for Healthcare Research and Quality. AHRQ Publication No. 07-0008. ISBN 1-58763-229-2.

Parthasarathy, S., Weisner, C., Hu, T. W., & Moore, C. (2001). Association of outpatient alcohol and drug treatment with health care utilization and cost: Revisiting the offset hypothesis. Journal of Studies on Alcohol, 62(1), 89-97.

Santibanez, S. S., Garfein, R. S., Swartzendruber, A., Purcell, D. W., Paxton, L. A., & Greenberg, A. E. (2006). Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. Journal of Urban Health, 83(1), 86-100.

Savage, C., Gillespie, G. L., & Lindsell, C. J. (2008). Health status and access to care for homeless adults with problem alcohol and drug use. Journal of Addictions Nursing, 19(1), 27-33.

Starrels, J. L., Barg, F. K., & Metlay, J. P. (2009). Patterns and determinants of inappropriate antibiotic use in injection drug users. Journal of General Internal Medicine, 24(2), 263-269.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2007). Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293.

Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2007). The NSDUH Report: Sexually Transmitted Diseases and Substance Use. Rockville, MD.

Tobias, C. R., Cunningham, W., Cabral, H. D., Cunningham, C. O., Eldred, L., Naar-King, S., et al. (2007). Living with HIV but without medical care: Barriers to engagement. Aids Patient Care and Stds, 21(6), 426-434.

Turner, B. J., Laine, C., Yang, C. P., & Hauck, W. W. (2003). Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization. Clinical Infectious Diseases, 37(Suppl. 5), S457-S463.

Washington State Screening, Brief Intervention, Referral and Treatment Project. (2008). Preliminary Results. Medical Cost Outcomes Substance Use Patterns Substance Use Outcomes. Olympia, Washington: Washington State Department of Social and Health Services.

White, A. G., Birnbaum, H. G., Mareva, M. N., Daher, M., Vallow, S., Schein, J., et al. (2005). Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm, 11(6), 469-479.

Wickizer, T. M., Campbell, K., Krupski, A., & Stark, K. (2000). Employment outcomes among AFDC recipients treated for substance abuse in Washington State. The Milbank Quarterly, 78(4), 585-608.

Wickizer, T. M., Krupski, A., Stark, K. D., Mancuso, D., & Campbell, K. (2006). The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington State. [Article]. Milbank Quarterly, 84(3), 555-576.

Wilkinson, J. D., Zhao, W., Arnsten, J. H., Knowlton, A. R., Mizuno, Y., Shade, S. B., et al. (2007). Longitudinal correlates of health care-seeking behaviors among HIV-seropositive injection drug users - How can we intervene to improve health care utilization? JAIDS-Journal of Acquired Immune Deficiency Syndromes, 46, S120-S126.

Zywiak, W. H., Hoffmann, N. G., Stout, R. L., Hagberg, S., Floyd, A. S., & DeHart, S. S. (1999). Substance abuse treatment cost offsets vary with gender, age, and abstinence likelihood. Journal of Health Care Finance, 26(1), 33.